Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Eagle Point Income Company Inc. Prices Offering of Preferred Stock
-
Eagle Point Income Company Inc. Announces Offering of Preferred Stock
-
Harrow Health (HROW) Prices 3.38M Share Offering at $17.75/sh
-
Harrow Prices $60 Million Public Offering of Common Stock
-
Harrow Health (HROW) Announces Proposed Share Offering
-
Harrow Announces Proposed Public Offering of Common Stock
-
Blade Air Mobility initiated with Buy at Ladenburg Thalmann, shares surge 10%
-
Ladenburg Thalmann Starts Blade Air Mobility (BLDE) at Buy, $13 PT
-
Instant View: US June CPI a welcome disinflation signal for Fed
-
Vertical Capital Income Fund Announces Sale of Majority of Investment Portfolio in Advance of Expected New Investment Advisory Agreement with Carlyle
-
Saratoga Investment Corp. Announces Fiscal First Quarter 2024 Financial Results
-
Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
-
Axsome Therapeutics (AXSM) Prices 3M Share Offering at $75/sh
-
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
-
Golden Star Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Rights
-
Advisor Group Rebrands As Osaic
-
Jaguar Health's (JAGX) Napo Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer
-
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC)
-
Encore Financial Group Joins Advisor Group to Improve Client Experience and Accelerate Growth
-
Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering
-
Auddia Announces Closing of $3.1 Million Registered Direct Offering of Common Stock
-
Auddia Announces Closing of $3.1 Million Registered Direct Offering of Common Stock
-
Auddia Announces Closing of $3.1 Million Registered Direct Offering of Common Stock
-
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference
-
Advisor Group Welcomes Four Financial Advisors with $410 Million in AUA to the Firm
-
Capital Southwest Corporation Closes Public Offering of 7.75% Notes due 2028
-
Coeptis Therapeutics (COEP) Announces Pricing of $3.5 Million Underwritten Offering
-
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten Offering
-
Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice
-
Auddia Inc. (AUUD) Prices $3.1 Million Registered Direct Offering of Common Stock
-
Auddia Announces Pricing of $3.1 Million Registered Direct Offering of Common Stock Priced At-The-Market
-
Auddia Announces Pricing of $3.1 Million Registered Direct Offering of Common Stock Priced At-The-Market
-
Auddia Announces Pricing of $3.1 Million Registered Direct Offering of Common Stock Priced At-The-Market
-
Capital Southwest Corp (CSWC) Prices $62.5M Notes Offering
-
Capital Southwest Corporation Prices Public Offering of $62.5 million 7.75% Notes due 2028
-
Capital Southwest Corp (CSWC) Announces Notes Offering
-
Capital Southwest Corporation Announces Offering of Notes
-
Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Check-Cap (CHEK) Announces Review of Strategic Alternatives and Reduction in Workforce
-
Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce
-
Engine Capital Issues Letter to the Board of Directors of Avantax Regarding the Urgent Need to Explore Strategic Alternatives (AVTA)
-
Engine Capital Issues Letter to the Board of Directors of Avantax Regarding the Urgent Need to Explore Strategic Alternatives
-
Advisor Group Accelerates Evolution of Ria Channel with Addition of Seasoned Industry Executive
-
Kiora Pharmaceuticals (KPRX) Prices $5M Share Offering at $1.10/sh
-
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
-
Advisor Group Closes First Ever NXT Conference and Announces Date to Unveil New Combined Brand
-
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
-
Biodexa Pharmaceuticals (BDRX) Announces 22.14M Share Offering at $0.15/sh
-
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
-
Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh

